The genetics of multiple sclerosis. A review

Biomedicine and Pharmacotherapy

Volumn 53, Issue 8, 1999, Pages 358-370

  Kaiman, B ^a   Lublin, F D ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Genetics; Multiple sclerosis; Pathogenesis

Indexed keywords

CYTOKINE; GLYCOPROTEIN; GROWTH FACTOR; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN PROTEIN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

AUTOIMMUNE DISEASE; CHROMOSOME 6P; ENVIRONMENTAL FACTOR; EPIDEMIC; ETHNIC GROUP; GENE LOCUS; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETICS; GEOGRAPHIC DISTRIBUTION; HAPLOTYPE; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MIGRATION; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; PRIORITY JOURNAL; REVIEW; TELOMERE; TWIN CONCORDANCE;

EID: 0033197842     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(99)80107-3     Document Type: Article

References (183)

1. Allen M, Sandberg-Wollheim M, Sjogrn K, et al. Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. Hum Immunol 1994 ; 39 : 41-8.
2. Alter M, Hapern L, Kurland LT, et al. Multiple sclerosis in Israel: Prevalence among immigrants and native inhabitants. Arch Neurol 1962 ; 7 : 253-63.
3. Alter M, Leibowitz U, Speer J. Risk of multiple sclerosis related to age of immigration to Israel. Arch Neurol 1966 ; 15 : 234-7.
4. Anderson S, Bankier AT, Barell BG, et al. Sequence and organization of the human mitochondrial genome. Nature 1981 ; 290 : 457-64.
5. Beall SS, Biddison WE, McFarlin DE, et al. Susceptibility for multiple sclerosis is determined, in part, by inheritance of a 175 kb region of the TCR Vβ-chain locus and HLA class II genes. J Neuroimmunol 1993 ; 45 : 53-60.
6. Beall SS, Concannon P, Charmley P, et al. The germline repertoire of T-cell receptor β-chain genes in patients with chronic progressive multiple sclerosis. J Neuroimmunol 1989 ; 21 : 59-66.
7. Bell RB, Ramachandran S. The relationship of TAP1 and TAP2 dimorphisms to multiple sclerosis susceptibility. J Neuroimmunol 1995 ; 59 : 201-4.
8. Bennetts BH, Teutsch SM, Heard RN, et al. TAP2 polymorphisms in Australian multiple sclerosis patients. J Neuroimmunol 1995 ; 59 ; 113-21.
9. Bobowick AR, Kurtzke JF, Brody JF, et al. Twin study of multiple sclerosis. An epidemiologic inquiry. Neurology 1978 ; 28 : 978-87.
10. Boylan KB, Takahashi N, Paty DW et al. DNA length polymorphism 5' to the myelin basic protein gene is associated with multiple sclerosis. Ann Neurol 1990 ; 27 : 291-7.
11. Braun N, Michel U, Ernst BP, et al. Gene polymorphism at position-308 of the tumor necrosis factor alpha (TNFα) in multiple sclerosis and its influence on the regulation of TNFα production. Neurosci Lett 1996 ; 215 : 75-8.
12. Brown MD, Sun F, Wallace DC. Clustering of Caucasian Leber hereditary optic neuropathy patients containing the 11,778 or 14,484 mutations on an mtDNA lineage. Am J Hum Genet 1997 ; 60 : 381-7.
13. Bulman DE, Ebers GC. The geography of multiple sclerosis reflects genetic susceptibility. J Trop Geograph Neurol 1992 ; 2 : 66-72.
14. Chalmers RM, Robertson N, Compston DAS, Harding AE. Sequence of mitochondrial DNA in patients with multiple sclerosis. Ann Neurol 1996 ; 40 : 239-43.
15. Chalmers RM, Robertson N, Kellar-Wood H, Compston DAS, Harding AE. Sequence of the human homologue of a mitochondrially encoded murine transplantation antigen in patients with multiple sclerosis. J Neurol 1995 ; 242 : 332-4.
16. Chataway J, Feakes R, Coraddu F, et al. The genetics of multiple sclerosis: Principles, background and updated results of the United Kingdom systematic genome screen. Brain 1998 ; 121 : 1869-87.
17. Chofflon M, Juillard C, Juillard P, et al. Tumor necrosis factor a production as a possible predictor of relapse in patients with multiple sclerosis. Eur Cytokine Netw 1992 ; 3 : 523-31.
18. Clerici N, Fernandez M. Restriction fragment length polymorphism analysis of HLA-DR- and DQ-linked alleles in multiple sclerosis in Spain. J Neuroimmunol 1992 ; 41 : 245-8.
19. Compston A. Genetic factors in the aetiology of multiple sclerosis. In: McDonald WI, Silberberg DH, eds. Multiple Sclerosis. Toronto: Butterworths; 19XX. p. 56-73.
20. Cowan EP, Pierce ML, McFarland HF, McFarlin DE. HLA-DR and -DQ allelic sequences in multiple sclerosis patients are identical to those found in the general population. Hum Immunol 1991 ; 32 : 203-10.
21. Crusius JBA, Pena AS, van Osten BW, et al. Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis. Lancet 1995 ; 346 : 979.
22. Curtius F. Multiple Sklerose und Erbanlange. Leipzig: Thieme; 1933.
23. Curtius F, Speer H. Multiple sklerose und erbanlage II. Z.ges. Neurol Psychiat 1937 ; 160 : 226-45.
24. Davenport CB. Multiple sclerosis from the standpoint of geographic distribution and race. Arch Neurol 1922 ; 8 : 51-8.
25. Dean G. Annual incidence, prevalence and mortality of multiple sclerosis in white South African born and in white immigrants to South Africa. Br Med J 1967 ; 2 : 724-30.
26. Dekker JW, Easteal S, Jakobsen IB, et al. HLA-DPB1 alleles correlate with risk for multiple sclerosis in Caucasoid and Cantonese patients lacking the high-risk DQB1 *0601 allele. Tissue Antigens 1993 ; 41 : 31-6.
27. Doolittle TH, Myers RH, Lehrich JR et al. Multiple sclerosis in sibling pairs: Clustered onset and familial predisposition. Neurology 1990 ; 40 : 1546-52.
28. Ebers GC. Genetic factors in multiple sclerosis. Neurol Clin 1983 ; 1 : 645-54.
29. Ebers GC. Multiple sclerosis and other demyelinating diseases. In: Asbury A, McKahnn G, McDonald I, eds. Diseases of the Nervous System. Philadelphia: WB Saunders Company; 19XX. p. 1268-81.
30. Ebers GC, Bulman DE, Sadovnick AD, et al. A population-based twin study in multiple sclerosis. N Eng J Med 1986 ; 315 : 1638-42.
31. Ebers GC, Kukay K, Bulman DE, et al. A full genome search in multiple sclerosis. Nature Genet 1996 ; 13 : 472-6.
32. Ebers GC, Paty DW, Stiller CR, et al. HLA typing in multiple sclerosis sibling pairs. Lancet 1982 ; i : 88-90.
33. Ebers GC, Sadovnick AD. The role of genetic factors in multiple sclerosis susceptibility. J Neuroimmunol 1994 ; 54 : 1-17.
34. Ebers GC, Sadovnick AD, Risch NJ, et al. A genetic basis for familial aggregation in multiple sclerosis. Nature 1995 ; 377 : 150-1.
35. Eichhorst H. Uber infantile und hereditare multiple Sklerose. Virchows Arch Path Anat 1896 ; 146 : 173-92.
36. Elian M, Alonso A, Awad J, et al. HLA association with multiple sclerosis in Sicily and Malta. Dis Markers 1987 ; 5 : 89-99.
37. Elian M, Nightingale S, Dean G. Multiple sclerosis among the United Kingdom born children of immigrants from the Indian subcontinent, Africa and the West Indies. J Neurol Neurosurg Psychiatry 1990 ; 53 : 906-11.
38. Enstrom JE, Operskalski EA. Multiple sclerosis among Spanish surnamed Californians. Neurology 1978 ; 28 : 434-8.
39. Eoli M, Pandolfo M, Amoroso A, et al. Evidence of linkage between susceptibility to multiple sclerosis and HLA class II loci in Italian multiplex families. Eur J Hum Genet 1995 ; 3 : 303-11.
40. Epplen C, Jackel S, Eduardo JM, et al. Genetic predisposition to multiple sclerosis as revealed by immunoprinting. Ann Neurol 1997 ; 41 : 341-52.
41. Feakes R, Chataway J, Sawcer S, et al. Susceptibility to multiple sclerosis and the immunoglobulin heavy chain gene cluster Ann Neurol 1998 ; 44 : 984.
42. Flanigan KM, Johns DR. Association of the 11,778 mitochondrial DNA mutation and demyelinating disease. Neurology 1993 ; 43 : 2720-2.
43. Fogdell A, Hillert J, Sachs C, et al. The multiple sclerosis and narcolepsy-associated HLA class II haplotype includes the DRB5*0101 allele. Tissue Antigens 1995 ; 46 : 333-6.
44. Fogdell A, Olerup O, Fredrikson S, et al. Linkage analysis of HLA class II genes in Swedish multiplex families with multiplex sclerosis. Neurology 1997 ; 48 : 758-62.
45. Francis DA, Batchelor JR, McDonald WI, et al. Multiple sclerosis in north-east Scotland. An association with HLA-DQw1. Brain 1987 ; 110 : 181-96.
46. Francis DA, Batchelor JR, McDonald WI, et al. HLA genetic determinants in familial MS. Tissue Antigens 1987 ; 29 : 7-12.
47. Francis DA, Thompson AJ, Brookes P, et al. Multiple sclerosis and HLA: Is the susceptibility gene really HLA-DR or HLA-DQ? Hum Immunol 1991 ; 32 : 119-24.
48. Fredrikson S, Michelsberg J, Hillert J, et al. Conjugal multiple sclerosis: Immunogenetic characterization and analysis of T-and B-cell reactivity to myelin proteins. Neurology 1992 ; 42 : 577-82.
49. French Research Group on Multiple Sclerosis. Multiple Sclerosis in 54 twinship: Concordance rate is independent of zygosity. Ann Neurol 1992 ; 32 : 724-7.
50. Fugger L, Sandberg-Wollheim M, Morling N, et al. The germline repertoire of T-cell receptor β-chain genes in patients with relapsing/remitting multiple sclerosis or optic neuritis. Immunogenet 1990 ; 31 : 178-80.
51. Garcia-Merino A, Alper CA, Usuku K, et al. Tumor Necrosis Factor (TNF) microsatellite haplotypes in relation to extended haplotypes, susceptibility to diseases associated with the major histocompatibility complex and TNF secretion. Hum Immunol 1996 ; 50 : 11-21.
52. Ghabanbasani MZ, Gu XX, Spaepen M, et al. Importance of HLA-DRB1 and DQA1 genes and of the amino acid polymorphisms in the functional domain of DRβ1-chain in multiple sclerosis. J Neuroimmunol 1995 ; 59 : 77-82.
53. Gorodezky C, Najera R, Rangel BE, et al. Immunogenetic profile of multiple sclerosis in Mexicans. Hum Immunol 1986 ; 6 : 364-74.
54. Gronning M, Mellgren SI. Multiple sclerosis in the two northernmost counties of Norway. Acta Neurol Scand 1985 ; 72 : 321-7.
55. Gyodi E, Tauszik T, Petranyi G, et al. The HLA antigen distribution in a gypsy population in Hungary. Tissue Antigen 1981 ; 18 : 1-12.
56. Haegert DG, Francis GS. Contribution of a single DQ β-chain residue to multiple sclerosis in French Canadians. Hum Immunol 1992 ; 34 : 85-90.
57. Haegert DG, Francis GS. HLA-DQ polymorphisms do not explain HLA class II associations with multiple sclerosis in two Canadian patient groups. Neurology 1993 ; 43 : 1207-10.
58. Haegert DG, Michaud M, Schwab C, et al. HLA-DR β, DQ α and DQ β restriction fragment length polymorphisms in multiple sclerosis. J Neurosci Res 1989 ; 23 : 46-54.
59. Haegert DG, Swift FV, Benedikz J. Evidence for a complex role of HLA class II genotypes in susceptibility to multiple sclerosis in Iceland. Neurology 1996 ; 46 : 1107-11.
60. Haines JL, Terwedow HA, Burgess K, et al. Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. Hum Mol Genet 1998 ; 7 : 1229-34.
61. Hanefeld FA, Ernst BP, Wilichowski E, Cristen HJ. Leber's hereditary optic neuropathy mitochondrial DNA mutations in childhood multiple sclerosis. Neuropediatrics 1994 ; 25 : 331.
62. Harding AE, Sweeney MG, Miller DH, et al. Occurrence of multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. Brain 1992 ; 115 : 979-89.
63. Hashimoto LL, Mak TW, Ebers GC. T-cell receptor α-chain polymorphism in multiple sclerosis. J Neuroimmunol 1992 ; 40 : 41-8.
64. Hashimoto LL, Walter MA, Cox DW, Ebers GC. Immunoglobulin heavy chain variable region polymorphisms and multiple sclerosis susceptibility. J Neuroimmunol 1993 ; 47 : 77-84.
65. Hauser SL, Fleischnick E, Weiner HL, et al. Extended major histocompatibility complex haplotypes in patients with multiple sclerosis. Neurology 1989 ; 39 : 275-7.
66. Hawkins BR, Yu YL, Huang CY. No apparent association between HLA and multiple sclerosis in southern Chinese. J Neurol Neurosurg Psychiatry 1988 ; 51 : 443-5.
67. Hawkins SA, Cullen C, Middteton D, Morrow JI. HLA antigens and multiple sclerosis in Northern Ireland. Irish J Med Sci 1990 ; 159 : 68-70.
68. He B, Navikas V, Lundahl J, et al. Tumor necrosis factor alpha 308 alleles in multiple sclerosis. J Neuroimmunol 1995 ; 63 : 143-7.
69. He B, Xu C, Yang B, et al. Linkage and association analysis of genes encoding cytokines and myelin proteins in multiple sclerosis. J Neuroimmunol 1998 ; 86 : 13-9.
70. He B, Yang B. Lundahl J, et al. The myelin basic protein gene in multiple sclerosis: Identification of discrete alleles of a 1.3 kb tetranucleotide repeat sequence. Acta Neurol Scand 1998 ; 97 : 46-51.
71. Heltberg A, Holm NV. Concordance in twins and recurrence in sibship in multiple sclerosis. Lancet 1982 ; i : 1068.
72. Hillert J. Human leukocyte antigen studies in multiple sclerosis. Ann Neurol 1994 ; 36 Suppl : S15-17.
73. Hillert J. Immunoglobulin constant region gene polymorphism in multiple sclerosis. J Neuroimmunol 1993 ; 43 : 9-14.
74. Hillert J, Kall T, Vrethem M, et al. The HLA-Dw2 haplotype segregates closely with multiple sclerosis in multiplex families. J Neuroimmunol 1994 ; 50 : 95-100.
75. Hillert J, Leng C, Olerup O. No association with germline T-cell receptor β-chain gene alleles or haplotypes in Swedish patients with multiple sclerosis. J Neuroimmunol 1991 ; 32 : 141-7.
76. Hillert J, Olerup O. Multiple sclerosis is associated with genes within and close to the HLA-DR-DQ subregion on a normal DR15,DQ6,Dw2 haplotype. Neurology 1993 ; 43 : 163-8.
77. Hockertz MK, Paty DW, Beall SS. Susceptibility to relapsing-progressive multiple sclerosis is associated with inheritance of genes linked to the variable region of TCR β locus: Use of effected family-based controls. Am J Hum Genet 1998 ; 62 : 373-85.
78. Howell WM, Sage DA, Evans PR, et al. No association between susceptibility to multiple sclerosis and HLA-DPB1 alleles in the French Canadian population. Tissue Antigens 1991 ; 37 : 156-60.
79. Jersild C, Fog T, Hansen GS, et al. Histocompatibility determinants of multiple sclerosis, with special reference to clinical course. Lancet 1973 ; ii : 1221-5.
80. Jershild C, Kurtzke JF, Riisom K, et al. Multiple sclerosis in the Faro Islands. VI. Studies of HLA markers. Tissue Antigens 1993 ; 42 : 105-10.
81. Kalman B, Alder H. Is the mitochondrial DNA involved in determining susceptibility to multiple sclerosis? Acta Neurol Scand 1998 ; 98 : 232-7.
82. Kalman B, Li S, Chatterjee D, O'Connor D, Voehl MR, Brown MD, et al. Large screening of the mitochondrial DNA reveals no pathogenic or polymorphic mutations but a haplotype associated with multiple sclerosis in Caucasians. Acta Neurol Scand 1999 ; 99 : 16-25.
83. Kalman B, Lublin FD, Alder H. Mitochondrial DNA mutations in multiple sclerosis. Multiple Sclerosis 1995 ; 1 : 32-6.
84. Kalman B, Lublin FD, Alder H. Characterization of the mitochondrial DNA in multiple sclerosis. J Neurol Sci 1996 ; 140 : 75-89.
85. Kalman B, Rodriguez-Valdez JL, Bosch U, Lublin FD. Screening for Leber's hereditary optic neuropathy associated mitochondrial DNA mutations in patients with prominent optic neuritis. Multiple Sclerosis 1997 ; 2 : 279-82.
86. Kalman B, Takacs K, Gyodi E, et al. Sclerosis multiplex in gypsies. Acta Neurol Scand 1991 ; 84 : 1981-5.
87. Kellar-Wood H, Robertson N, Govan GG, Compston DAS, Harding AE. Leber's hereditary optic neuropathy mitochondrial DNA mutations in multiple sclerosis. Ann Neurol 1994 ; 36 : 109-12.
88. Kellar-Wood HF, Wood NW, Holmans P, et al. Multiple sclerosis and the HLA D region: Linkage and association studies. J Neuroimmunol 1995 ; 58 : 183-90.
89. Kinnunen E, Juntunen J, Ketonen L, et al. Genetic susceptibility to multiple sclerosis: A co-twin study of a nationwide series. Arch Neurol 1988 ; 45 : 1108-11.
90. Kinnunen E. Koskimies S, Lagerstedt A, Wikstrom J. Histocompatibility antigens in familial multiple sclerosis in a high-risk area of the disease. J Neurol Sci 1984 ; 65 : 147-55.
91. Koch-Henriksen N. An epidemiological study of multiple sclerosis. Acta Neurol Scand 1989 ; 124 : 1-123.
92. Kuokannen S, Gschwend M, Rioux JD, et al. Genome-wide scan of multiple sclerosis in Finnish multiplex families. Am J Hum Genet 1997 ; 61 : 1379-87.
93. Kurdi A, Ayesh I, Abdallat A, et al. Different B-lymphocyte alloantigens associated with multiple sclerosis in Arabs and northern Europeans. Lancet 1977 ; i : 1123-5.
94. Kuroiwa Y, Shibasaki H, Ikeda M. Prevalence of multiple sclerosis and its north to south gradient in Japan. Neuroepidemiol 1983 ; 2 : 62-9.
95. Kurtzke JF. A reassessment of the distribution of multiple sclerosis. Part one. Acta Neurol Scand 1975 ; 51 : 110-36.
96. Kurtzke JF. A reassessment of the distribution of multiple sclerosis. Part two. Acta Neurol Scand 1975 ; 51 : 137-57.
97. Kurtzke JF. Epidemiologie evidence for multiple sclerosis as an infection. Clin Microbiol Rev 1993 ; 6 : 382-427.
98. Kurtzke JF, Beebe GW, Norman JE. Epidemiology of multiple sclerosis in US veterans, 1. Race, sex and geographic distribution. Neurology 1979 ; 29 : 1228-35.
99. Kurtzke J, Hyllested K. Multiple sclerosis: An epidemic disease in the Faroes. Trans Am Neurol Assoc 1975 ; 100 : 213-5.
100. Lee F, MacDonald AM, Aldren Turner JW. Leber's disease with symptoms resembling disseminated sclerosis. J Neurol Neurosurg Psychiatry 1964 ; 27 : 415-21.
101. Liblau R, van Endert PM, Sandberg-Wollheim M, et al. Antigen processing gene polymorphisms in HLA-DR2 multiple sclerosis. Neurology 1993 ; 43 : 1192-7.
102. Limburg CC. The geographic distribution of multiple sclerosis and its estimated prevalence in the United States. Proc Assoc Res Nerv Ment Dis 1950 ; 28 : 15-24.
103. Lord D, O'Fareil AG, Stauton H, et al. The inheritance of MS susceptibility. Ir J Med Sci 1990 ; 159 : 1-20.
104. Lynch SG, Rose JW, Petajan JH, et al. Discordance of T-cell receptor β-chain genes in familial multiple sclerosis. Ann Neurol 1991 ; 30 : 402-10.
105. Lynch SG, Rose J, Petajan JH, Leppert M. Discordance of the T-cell receptor α-chain in familial multiple sclerosis. Neurology 1992 ; 42 : 839-44.
106. Mackay RP, Myrianthopoulos NC. Multiple sclerosis in twins and their relatives. Final report. Arch Neurol Psych 1966 ; 15 : 449-62.
107. Malfroy R, Viratelle C, Coppin H, et al. Polymorphic tri- and tetranucleotide repeats in exon 1 and 8 of the Myelin Oligodendrocyte Glycoprotein (MOG) gene. Hum Genet 1995 ; 96 : 737-8.
108. Marcadet A, Massart C, Semana G, et al. Association of class II HLA-DQ beta chain restriction fragments with multiple sclerosis. Immunogenet 1985 ; 22 : 93-6.
109. Marrosu MG, Muntoni F, Murru MR, et al. Sardinian multiple sclerosis is associated with HLA-DR4: A serologic and molecular analysis. Neurology 1988 ; 38 : 1749-53.
110. Mayr-Wohlfart U, Paulus C, Henneberg A, Rodel G. Mitochondrial DNA mutations in multiple sclerosis patients with severe optic involvement. Acta Neurol Scand 1996 ; 94 : 167-71.
111. McLeod J, Hammond S, Hallpike J. Epidemiology of multiple sclerosis in Australia. Med J Aust 1994 ; 160 : 117-22.
112. Mertens C, Brassat D, Reboul J, et al. A systemic study of oligodendrocyte growth factors as candidates for genetic susceptibility to MS. Neurology 1998 ; 51 : 748-53.
113. Miller D, Hammond S, McLeod J, et al. Multiple sclerosis in Australia and New Zealand: Are the determinants genetic or environmental? J Neurol Neurosurg Psychiatry 1990 ; 53 : 903-5.
114. Mumford CJ, Wood NW, Kellar-Wood H, et al. The British Isles survey of multiple sclerosis in twins. Neurology 1994 ; 44 : 11-5.
115. Mycko M, Kowalski W, Kwinkowski M, et al. Multiple sclerosis: The frequency of allelic forms of tumor necrosis factors and lymphotoxin-alpha. J Neuroimmunol 1998 ; 84 : 198-206.
116. Mycko MP, Kwinkowski M, Tronczynska E, et al. Multiple Sclerosis: The increased frequency of the ICAM-1 exon 6 gene point mutation genetic type K469. Ann Neurol 1998 ; 44 : 70-5.
117. Naito C, Kuroiwa Y, Itoyama T, et al. HLA and Japanese multiple sclerosis. Tissue Antigens 1978 ; 12 : 19-24.
118. Nishimura M, Obayashi H, Ohta M, Uchiyama T, Hao Q, Saida T. No association of the 11,778 mitochondrial DNA mutation and multiple sclerosis in Japan. Neurology 1995 ; 45 : 1333-4.
119. Oksenberg JR, Seboun E, Hauser SL. Genetics of demyelinating diseases. Brain Pathol 1996 ; 6 : 289-302.
120. Oksenberg JR, Sherritt M, Begovich AB, et al. T-cell receptor Vα and Cαa alleles associated with multiple sclerosis and myasthenia gravis. Proc Natl Acad Sci 1989 ; 86 : 988-92.
121. Olerup O, Carlsson B, Wallin J, et al. Genomic HLA-typing by RFLP-analysis Using DR β and DQ β cDNA Probes Reveals Normal DR-DQ Linkages in Patients with Multiple Sclerosis.
122. Olerup O, Hillert J. HLA class II-associated genetic susceptibility in multiple sclerosis: A critical evaluation. Tissue Antigens 1991 ; 38 : 1-15.
123. Olerup O, Hillert J, Fredrikson S, et al. Primary chronic progressive and relapsing/remitting multiple sclerosis: Two immunogenetically distinct disease entities. Proc Natl Acad Sci 1989 ; 86 : 7113-7.
124. Olsen NK, Hansen AW, Norby S, Edal AL, Jorgensen JR, Rosenberg T. Leber's hereditary optic neuropathy associated with a disorder indistinguishable from multiple sclerosis in a male harboring the mitochondrial DNA 11,778 mutation. Acta Neurol Scand 1995 ; 91 : 326-9.
125. Pandey JP, Goust JM, Salier JP. Immunoglobulin G heavy chain (Gm) allotypes in multiple sclerosis. J Clin Invest 1981 ; 67 : 1797-800.
126. Papiha SS, Duggan-Keen M, Roberts DF. Factor B (BF) allotypes and multiple sclerosis in north-east England. Hum Heredity 1991 ; 41 : 397-402.
127. Poser CM. The dissemination of multiple sclerosis: A Viking saga? A historical essay. Ann Neurol 1994 ; 36 Suppl 2 : S231-43.
128. Poser C, Vernant J. La sclerose en plaques dans la race noire. Bull Soc Pathol Exot Filiales 1993 ; 86 : 1-5.
129. Pratt RTC, Compston ND, McAlpine D. The familial incidence of multiple sclerosis and its significance. Brain 1951 ; 74 : 191-232.
130. Riordan-Eva P, Sanders MD, Govan GG, Sweeney MG, Da Costa J, Harding AE. The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain 1995 ; 118 : 319-37.
131. Roberts DF. Consanguinity and multiple sclerosis in Orkney. Gen Epidemiol 1991 ; 8 : 147-51.
132. Roberts DF, Roberts MJ, Poskanzer DC. Genetic analysis of multiple sclerosis in Shetland. J Epidem Comm Health 1983 ; 37 : 281-5.
133. Robertson NP, Clayton D, Fraser MA, et al. Clinical concordance in sibling pairs with multiple sclerosis. Neurology 1996 ; 47 : 347-52.
134. Rosati G, Aiello I, Granieri E, et al. Incidence of MS in Macomer, Sardinia, 1912-1981. Neurology 1986 ; 36 : 1419.
135. Roth MP, Coppin H, Descoins P, et al. HLA-DPB1 gene polymorphism and multiple sclerosis: A large case-control study in the southwest of France. J Neuroimmunol 1991 ; 34 : 215-22.
136. Roth MP, Dolbois L, Borot N, et al. Myelin Oligodendrocyte Glycoprotein (MOG) gene polymorphism and multiple sclerosis: No evidence of disease association with MOG. J Neuroimmunol 1995 ; 61 : 117-22.
137. Roth MP, Nogueira L, Coppin H, et al. Tumor necrosis factor polymorphism in multiple sclerosis: No additional association independent of HLA. J Neuroimmunol 1994 ; 51 : 93-9.
138. Sadovnick AD. Familial recurrence risk and inheritance of multiple sclerosis. Curr Opin Neurol Neurosurg 1993 ; 6 : 189-94.
139. Sadovnick AD, Armstrong H, Rice GPA, et al. A population-based twin study of multiple sclerosis in twins: Update. Ann Neurol 1993 ; 33 : 281-5.
140. Sadovnick AD, Baird PA. The familial nature of multiple sclerosis: Age-corrected empiric recurrence risks for children and siblings of patients. Neurology 1988 ; 38 : 990-1.
141. Sadovnick AD, Baird PA, Ward RH. Multiple sclerosis: Updated risks for relatives. Am J Med Gen 1988 ; 29 : 533-41.
142. Sadovnick AD, Bulman D, Ebers GC. Parent-child concordance in multiple sclerosis. Ann Neurol 1991 ; 29 : 252-5.
143. Sadovnick AD, Ebers GC, Dyment DA, et al. Evidence for genetic basis of multiple sclerosis. Lancet 1996 ; 347 : 1728-30.
144. Sadovnick AD, MacLeod PMJ. Familial nature of multiple sclerosis: Empiric risks for first, second and third degree relatives of patients. Neurology 1981 ; 31 : 1039-41.
145. Sadovnick DA, Yee I, Ebers GC, Risch NJ. Effect of Age at Onset and Parental Disease Status on Sibling Risks for MS. 1998 ; 50 : 719-23.
146. Salier JP, Sesboue R, Martin-Moncliere C, et al. Combined influences of Gm and HLA phenotypes upon multiple sclerosis susceptibility and severity. J Clin Invest 1986 ; 78 : 533-8.
147. Sandberg-Wollheim M, Ciusani E, Salmaggi A, et al. An evaluation of tumor necrosis factor microsatellite alleles in genetic susceptibility to multiple sclerosis. Multiple Sclerosis 1995 ; 1 : 181-5.
148. Sawcer S, Jones HB, Feakes R, et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nature Genet 1996 ; 13 : 464-8.
149. Seboun E, Robinson MA, Doolittle TH, et al. A susceptibility locus for multiple sclerosis is linked to the T-cell receptor β-chain complex. Cell 1989 ; 57 : 1095-100.
150. Selmaj K, Raine CS, Canella B, Brosnan CF. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 1991 ; 87 : 949-54.
151. Semana G, Quillivic F, Madigand M, et al. HLA genetic factors involved in familial MS: RFLP study defines a particular DQw1 subtype associated with the disease. In: Confavreux C, Aimard G, Deic M, eds. Trends in European Multiple Sclerosis. New York: Elsevier; 1988. p. 21-6.
152. Skegg D, Corwin P, Craven R, et al. Occurrence of multiple sclerosis in the north and south of New Zealand. J Neurol Neurosurg Psychiatry 1987 ; 50 : 134-9.
153. Spurkland A, Celius EG, Knutsen I, el al. The HLA-DQ (alpha 1 *0102, beta 1 *0602) heterodimer may confer susceptibility to multiple sclerosis in the absence of the HLA-DR (alpha 1 *01, beta 1 *1501) heterodimer. Tissue Antigens 1997 ; 50 : 15-22.
154. Spurkland A, Knutsen I, Undlien DE, Vandal F. No association of multiple sclerosis to alleles at the TAP2 locus. Hum Immunol 1994 ; 39 : 299-301.
155. Spurkland A, Ronningen KS, Vandvik B, et al. HLA-DQA1 and HLA-DQB1 genes may jointly determine susceptibility to develop multiple sclerosis. Hum Immunol 1991 ; 30 : 69-75.
156. Stewart GJ, Basten A, Kirk RL. Strong linkage disequilibrium between HLA-Dw2 and BfS in multiple sclerosis ad in normal population. Tissue Antigens 1979 ; 14 : 86-97.
157. Stewart GJ, Teutsch SM, Castle M, et al. HLA-DR, DQA1 and DQB1 associations in Australian multiple sclerosis patients. Eur J Immunogen 1997 ; 24 : 81-92.
158. Sumner SM, Ebers GC. Multiple sclerosis susceptibility and the tumor necrosis factors. Am J Hum Genet 1993 ; 53 : S1086.
159. Sutherland JM. Observation on the prevalence of multiple sclerosis in northern Scotland. Brain 1956 ; 79 : 635-54.
160. Swingler RJ, Compston DAS. The distribution of multiple sclerosis in the United Kingdom. J Neurol Neurosurg Psychiatry 1986 ; 49 : 1115-24.
161. Swingler RJ, Kirk PF, Darke C, Compston DA. HLA and multiple sclerosis in south east Wales. J Neurol Neurosurg Psychiatry 1987 ; 50 : 1153-5.
162. Takacs K, Kalman B, Gyodi E, et al. Association between the Lack of HLA-DQw6 and the Low Incidence of Multiple Sclerosis in Hungarian Gypsies. 1990 ; 31 : 383-5.
163. Tienari PJ, Wikstrom J, Koskimies S, et al. Reappraisal of HLA in multiple sclerosis: Close linkage in multiplex families. Eur J Hum Genet 1993 ; 1 : 257-68.
164. Tienari PJ, Wikstrom J, Sajantila A, et al. Genetic susceptibility to multiple sclerosis linked to myelin basic protein gene. Lancet 1992 ; 340 : 987-91.
165. Tiwari JL, Terasaki PI. Multiple sclerosis. In: Tiwari JL, Terasaki PI, eds. HLA and Disease Associations. New York: Springier-Verlag; 1985. p. 152-67.
166. The Multiple Sclerosis Genetics Group. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nature Genet 1996 ; 13 : 469-71.
167. Thorsby E, Helgesen A, Solheim BG, Vandvik B. HLA antigens in multiple sclerosis. J Neurol Sci 1977 ; 32 : 187-93.
168. Torroni A, Lott MT, Cabell MF, Chen YS, Lavergne L, Wallace DC. mtDNA and the origin of Caucasians: Identification of ancient Caucasian-specific haplogroups, one of which is prone to a recurrent somatic duplication in the D-loop region. Am J Hum Genet 1994 ; 55 : 760-76.
169. Uitdehaag BMJ, Polman CH, Valk J, et al. Magnetic resonance imaging studies in multiple sclerosis twins. J Neurol Neurosurg Psychiatry 1989 ; 52 : 1417-9.
170. Vandenbroeck K, Opdenakker G, Goris A, et al. Interferon-γ gene polymorphism-associated risk for multiple sclerosis in Sardinia. Ann Neurol 1998 ; 44 : 841.
171. Vandevyver C, Raus P, Stinissen P, et al. Polymorphism of the tumor necrosis factor beta gene in multiple sclerosis and rheumatoid arthritis. Eur J Immunogenet 1994 ; 21 : 377-82.
172. Vandevyver C, Stinissen P, Cassiman JJ, Raus J. TAP1 and TAP2 transporter gene polymorphisms in multiple sclerosis: No evidence for disease association with TAP. J Neuroimmunol 1994 ; 54 : 35-40.
173. Vartdal F, Dollid L, Vandvik B, et al. Patients with multiple sclerosis carry DQB1 genes which encode shared polymorphic amino acid sequences. Hum Immunol 1989 ; 25 : 103-10.
174. Voskuhl RR, Martin R, McFarland HF. A functional basis for the association of HLA class II genes and susceptibility to multiple sclerosis: Cellular immune response to myelin basic protein in a multiplex family. J Neuroimmunol 1993 ; 42 : 187-92.
175. Voskuhl R, Goldstein AM, Simonis T, et al. DR2/DQw1 inheritance and haplotype sharing in affected siblings from multiple sclerosis families. Ann Neurol 1996 ; 39 : 804-7.
176. Wei S, Charmley P, Birchfield RI, et al. Human T-cell receptor V β gene polymorphism and multiple sclerosis. Am J Hum Genet 1995 ; 56 : 963-9.
177. Weinshenker BG. The natural history of multiple sclerosis. Neurol Clin 1995 ; 13 : 119-46.
178. Weinshenker BG, Santrach P, Bissonet AS, et al. Major histocompatibility complex class II alleles and the course and outcome of MS. A population-based study. Neurology 1998 ; 51 : 742-7.
179. Weinshenker BG, Wingerchuk DM, Liu Q, et al. Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis. Neurology 1997 ; 49 : 378-85.
180. Williams A, Eldridge R, McFarland H, et al. Multiple sclerosis in twins. Neurology 1980 ; 30 : 1139-47.
181. Wingerchuk D, Liu Q, Sobell J, et al. A population-based case-control study of the tumor necrosis factor alpha 308 polymorphism in multiple sclerosis. Neurology 1997 ; 49 : 626-8.
182. Wood NW, Holmans P, Clayton D, et al. No linkage or association between multiple sclerosis and the myelin basic protein gene in affected sibling pairs. J Neurol Neurosurg Psychiatry 1994 ; 57 : 1191-4.
183. Wood NW, Sawcer S, Kellar Wood HF, et al. A susceptibility gene for multiple sclerosis linked to immunoglobulin heavy chain variable region. J Neurol 1995 ; 242 : 677-82.